1. |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3): 209-249.
|
2. |
Bade BC, Dela Cruz CS. Lung cancer 2020: Epidemiology, etiology, and prevention. Clin Chest Med, 2020, 41(1): 1-24.
|
3. |
Postmus PE, Kerr KM, Oudkerk M, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2017, 28(suppl_4): Ⅳ1-Ⅳ21.1.
|
4. |
Yuan XS, Chen WC, Lin QR, et al. A propensity-matched analysis of stereotactic body radiotherapy and sublobar resection for stageⅠnon-small cell lung cancer in patients at high risk for lobectomy: The results in a Chinese population. J Thorac Dis, 2021, 13(3): 1822-1832.
|
5. |
Mimae T, Okada M. Are segmentectomy and lobectomy comparable in terms of curative intent for early stage non-small cell lung cancer? Thorac Cardiovasc Surg, 2020, 68(7): 703-706.
|
6. |
Gao Y, Chen J, Zhang J, et al. Radiofrequency ablation of primary non-small cell lung cancer: A retrospective study on 108 patients. J BUON, 2019, 24(4): 1610-1618.
|
7. |
Crocetti L, Bargellini I, Cioni R. Loco-regional treatment of HCC: current status. Clin Radiol, 2017, 72(8): 626-635.
|
8. |
Cao F, Xie L, Qi H, et al. Safety and efficacy of thermal ablation for subpleural lung cancers. Thorac Cancer, 2019, 10(6): 1340-1347.
|
9. |
Li G, Xue M, Chen W, et al. Efficacy and safety of radiofrequency ablation for lung cancers: A systematic review and meta-analysis. Eur J Radiol, 2018, 100: 92-98.
|
10. |
Wells GA, Shea B, O'Connell D, et al. The Newcastle Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
|
11. |
Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ, 2003, 327(7414): 557-560.
|
12. |
Alexander ES, Machan JT, Ng T, et al. Cost and effectiveness of radiofrequency ablation versus limited surgical resection for stage Ⅰ non-small-cell lung cancer in elderly patients: Is less more? J Vasc Interv Radiol, 2013, 24(4): 476-482.
|
13. |
Ambrogi MC, Fanucchi O, Dini P, et al. Wedge resection and radiofrequency ablation for stageⅠnonsmall cell lung cancer. Eur Respir J, 2015, 45(4): 1089-1097.
|
14. |
Hu H, Zhai B, Liu R, et al. Microwave ablation versus wedge resection for stageⅠ non-small cell lung cancer adjacent to the pericardium: Propensity score analyses of long-term outcomes. Cardiovasc Intervent Radiol, 2021, 44(2): 237-246.
|
15. |
Iguchi T, Hiraki T, Matsui Y, et al. Survival outcomes of treatment with radiofrequency ablation, stereotactic body radiotherapy, or sublobar resection for patients with clinical stageⅠnon-small-cell lung cancer: A single-center evaluation. J Vasc Interv Radiol, 2020, 31(7): 1044-1051.
|
16. |
Kim SR, Han HJ, Park SJ, et al. Comparison between surgery and radiofrequency ablation for stageⅠnon-small cell lung cancer. Eur J Radiol, 2012, 81(2): 395-399.
|
17. |
Kwan SW, Mortell KE, Talenfeld AD, et al. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer. J Vasc Interv Radiol, 2014, 25(1): 1-9.
|
18. |
Safi S, Rauch G, op den Winkel J, et al. Sublobar resection, radiofrequency ablation or radiotherapy in stageⅠnon-small cell lung cancer. Respiration, 2015, 89(6): 550-557.
|
19. |
Wang Y, Liu B, Cao P, et al. Comparison between computed tomography-guided percutaneous microwave ablation and thoracoscopic lobectomy for stageⅠnon-small cell lung cancer. Thorac Cancer, 2018, 9(11): 1376-1382.
|
20. |
Yao W, Lu M, Fan W, et al. Comparison between microwave ablation and lobectomy for stageⅠnon-small cell lung cancer: A propensity score analysis. Int J Hyperthermia, 2018, 34(8): 1329-1336.
|
21. |
Zemlyak A, Moore WH, Bilfinger TV. Comparison of survival after sublobar resections and ablative therapies for stageⅠnon-small cell lung cancer. J Am Coll Surg, 2010, 211(1): 68-72.
|
22. |
侯立泳, 高兴强, 王永, 等. 经皮微波消融与胸腔镜肺叶切除术治疗Ⅰ期非小细胞肺癌的疗效. 介入放射学杂志, 2019, 28(9): 851-854.
|
23. |
郑鑫林, 夏学阳, 张金周, 等. 胸腔镜下肺段切除与肺叶切除治疗临床Ⅰ期非小细胞肺癌疗效对比的Meta分析. 中国癌症杂志, 2016, 26(10): 854-860.
|
24. |
覃帮能, 刘触灵. CT诊断非小细胞肺癌TNM分期的临床价值. 重庆医学, 2017, 46(31): 4406-4408.
|
25. |
吴鹏, 庞瑶, 张宏毅, 等. 手术和射频消融治疗Ⅰ期非小细胞肺癌预后比较的Meta分析. 中华胸部外科电子杂志, 2020, 7(3): 164-173.
|
26. |
Aufranc V, Farouil G, Abdel-Rehim M, et al. Percutaneous thermal ablation of primary and secondary lung tumors: Comparison between microwave and radiofrequency ablation. Diagn Interv Imaging, 2019, 100(12): 781-791.
|
27. |
Palussiere J, Lagarde P, Aupérin A, et al. Percutaneous lung thermal ablation of non-surgical clinical N0 non-small cell lung cancer: Results of eight years' experience in 87 patients from two centers. Cardiovasc Intervent Radiol, 2015, 38(1): 160-166.
|
28. |
Yuan Z, Wang Y, Zhang J, et al. A Meta-analysis of clinical outcomes after radiofrequency ablation and microwave ablation for lung cancer and pulmonary metastases. J Am Coll Radiol, 2019, 16(3): 302-314.
|
29. |
Sharma A, Abtin F, Shepard JA. Image-guided ablative therapies for lung cancer. Radiol Clin North Am, 2012, 50(5): 975-999.
|
30. |
Ozturk A, Gullu YT. Excellence in non-small cell lung cancer staging by endobronchial-TBNA: Comparison with PET-CT and surgery. Minim Invasive Ther Allied Technol, 2019, 28(4): 213-219.
|